Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis
对于肌萎缩侧索硬化症患者，联合调节性 T 淋巴细胞和 IL-2 治疗一年后仍安全、可耐受且具有生物活性
期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.8
doi:10.1212/NXI.0000000000200019
Jason R Thonhoff, James D Berry, Eric A Macklin, David R Beers, Patricia A Mendoza, Weihua Zhao, Aaron D Thome, Fabio Triolo, James J Moon, Sabrina Paganoni, Merit Cudkowicz, Stanley H Appel
